5 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital

Page 1 of 5

In this article, we will discuss 5 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. If you want to read our detailed analysis of Akkaraju and Dybbs’ history, investment philosophy, and hedge fund performance, go directly to 15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital.

5. Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX)

Akkaraju and Dybbs’ Stake Value: $38,966,000
Percentage of Srini Akkaraju and Michael Dybbs’ 13F Portfolio: 4.81%
Number of Hedge Fund Holders: 13

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) is a clinical-stage biopharmaceutical business that develops and commercializes new therapeutics to treat rare hematologic disorders and malignancies. It was incorporated in 2007, and it stands fifth on the list of 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) currently has a $1.14 billion market capitalization.

On August 17, H.C. Wainwright analyst Robert Burns lowered the price target on Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) to $53 from $55 and kept a “Buy” rating on the shares after the second-quarter results. On August 13, Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) declared earnings for the second quarter of 2021. It posted earnings per share of -$0.92, missing the estimates by $0.13. 

The hedge fund chaired by Srini Akkaraju and Michael Dybbs owns 1.57 million shares in Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) worth over $38.97 million, representing 4.81% of their investment portfolio. Peter Kolchinsky’s RA Capital Management is the most significant stakeholder in Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) out of the 873 hedge funds tracked by Insider Monkey as of the second quarter of 2021. The hedge fund owns 9.01 million shares of the company, worth $224.30 million.



Page 1 of 5